Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
10,154
archived clinical trials in
Other Indications

Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis
A Phase 2a Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  8/19/2015
Clinical Trials of Arizona, Inc
mi
from
Glendale, AZ
Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis
A Phase 2a Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 8/19/2015
Clinical Trials of Arizona, Inc
mi
from
Glendale, AZ
Click here to add this to my saved trials
Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis
A Phase 2a Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  8/19/2015
Citrus Valley Medical Research, Inc.
mi
from
Glendora, CA
Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis
A Phase 2a Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 8/19/2015
Citrus Valley Medical Research, Inc.
mi
from
Glendora, CA
Click here to add this to my saved trials
Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis
A Phase 2a Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  8/19/2015
Stanford University Department of Urology
mi
from
Stanford, CA
Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis
A Phase 2a Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 8/19/2015
Stanford University Department of Urology
mi
from
Stanford, CA
Click here to add this to my saved trials
Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis
A Phase 2a Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  8/19/2015
Genitourinary Surgical Consultants
mi
from
Denver, CO
Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis
A Phase 2a Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 8/19/2015
Genitourinary Surgical Consultants
mi
from
Denver, CO
Click here to add this to my saved trials
Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis
A Phase 2a Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  8/19/2015
Women's Health Specialty Care
mi
from
Farmington, CT
Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis
A Phase 2a Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 8/19/2015
Women's Health Specialty Care
mi
from
Farmington, CT
Click here to add this to my saved trials
Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis
A Phase 2a Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  8/19/2015
Grove Hill Clinical Research
mi
from
New Britain, CT
Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis
A Phase 2a Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 8/19/2015
Grove Hill Clinical Research
mi
from
New Britain, CT
Click here to add this to my saved trials
Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis
A Phase 2a Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  8/19/2015
Manatee Medical Research Institute, LLC
mi
from
Bradenton, FL
Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis
A Phase 2a Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 8/19/2015
Manatee Medical Research Institute, LLC
mi
from
Bradenton, FL
Click here to add this to my saved trials
Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis
A Phase 2a Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  8/19/2015
Idaho Urologic Center
mi
from
Meridian, ID
Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis
A Phase 2a Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 8/19/2015
Idaho Urologic Center
mi
from
Meridian, ID
Click here to add this to my saved trials
Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis
A Phase 2a Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  8/19/2015
First Urology
mi
from
Jeffersonville, IN
Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis
A Phase 2a Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 8/19/2015
First Urology
mi
from
Jeffersonville, IN
Click here to add this to my saved trials
Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis
A Phase 2a Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  8/19/2015
Regional Urology
mi
from
Shreveport, LA
Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis
A Phase 2a Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 8/19/2015
Regional Urology
mi
from
Shreveport, LA
Click here to add this to my saved trials
Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis
A Phase 2a Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  8/19/2015
Lahey Clinic Medical Center
mi
from
Burlington, MA
Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis
A Phase 2a Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 8/19/2015
Lahey Clinic Medical Center
mi
from
Burlington, MA
Click here to add this to my saved trials
Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis
A Phase 2a Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  8/19/2015
Bay State Clinical Trials, Inc.
mi
from
Watertown, MA
Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis
A Phase 2a Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 8/19/2015
Bay State Clinical Trials, Inc.
mi
from
Watertown, MA
Click here to add this to my saved trials
Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis
A Phase 2a Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  8/19/2015
Female Pelvic Medicine and Urogynecology
mi
from
Grand Rapids, MI
Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis
A Phase 2a Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 8/19/2015
Female Pelvic Medicine and Urogynecology
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis
A Phase 2a Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  8/19/2015
CRC of Jackson and Southeast Urogynecology
mi
from
Jackson, MS
Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis
A Phase 2a Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 8/19/2015
CRC of Jackson and Southeast Urogynecology
mi
from
Jackson, MS
Click here to add this to my saved trials
Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis
A Phase 2a Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  8/19/2015
Arthur Smith Institute for Urology
mi
from
New Hyde Park, NY
Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis
A Phase 2a Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 8/19/2015
Arthur Smith Institute for Urology
mi
from
New Hyde Park, NY
Click here to add this to my saved trials
Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis
A Phase 2a Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  8/19/2015
University of Rochester, Department of Urology
mi
from
Rochester, NY
Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis
A Phase 2a Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 8/19/2015
University of Rochester, Department of Urology
mi
from
Rochester, NY
Click here to add this to my saved trials
Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis
A Phase 2a Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  8/19/2015
Alliance Urology Specialists
mi
from
Greensboro, NC
Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis
A Phase 2a Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 8/19/2015
Alliance Urology Specialists
mi
from
Greensboro, NC
Click here to add this to my saved trials
Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis
A Phase 2a Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  8/19/2015
Wake Forest University Health Sciences Medical Center
mi
from
Winston-Salem, NC
Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis
A Phase 2a Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 8/19/2015
Wake Forest University Health Sciences Medical Center
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis
A Phase 2a Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  8/19/2015
MetroHealth Med Ctr
mi
from
Cleveland, OH
Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis
A Phase 2a Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 8/19/2015
MetroHealth Med Ctr
mi
from
Cleveland, OH
Click here to add this to my saved trials
Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis
A Phase 2a Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  8/19/2015
Medical University of South Carolina Urology Ambulatory Care
mi
from
Charleston, SC
Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis
A Phase 2a Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 8/19/2015
Medical University of South Carolina Urology Ambulatory Care
mi
from
Charleston, SC
Click here to add this to my saved trials
Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis
A Phase 2a Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  8/19/2015
Carolina Urologic Research Center
mi
from
Myrtle Beach, SC
Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis
A Phase 2a Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 8/19/2015
Carolina Urologic Research Center
mi
from
Myrtle Beach, SC
Click here to add this to my saved trials
Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis
A Phase 2a Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  8/19/2015
Vanderbilt University Medical Center
mi
from
Nashville, TN
Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis
A Phase 2a Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 8/19/2015
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis
A Phase 2a Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  8/19/2015
Integrity Medical Research
mi
from
Mountlake Terrace, WA
Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis
A Phase 2a Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 8/19/2015
Integrity Medical Research
mi
from
Mountlake Terrace, WA
Click here to add this to my saved trials
Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis
A Phase 2a Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  8/19/2015
North Idaho Urology
mi
from
Coeur d'Alene, ID
Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis
A Phase 2a Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 8/19/2015
North Idaho Urology
mi
from
Coeur d'Alene, ID
Click here to add this to my saved trials
Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis
A Phase 2a Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  8/19/2015
William Beaumont Hospital
mi
from
Royal Oak, MI
Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis
A Phase 2a Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 8/19/2015
William Beaumont Hospital
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis
A Phase 2a Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  8/19/2015
Sheldon Freedman, MD
mi
from
Las Vegas, NV
Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis
A Phase 2a Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 8/19/2015
Sheldon Freedman, MD
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis
A Phase 2a Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  8/19/2015
Penn Presbyterian Medical Center
mi
from
Philadelphia, PA
Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis
A Phase 2a Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 8/19/2015
Penn Presbyterian Medical Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis
A Phase 2a Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  8/19/2015
Pacific Urological Research
mi
from
Victoria,
Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis
A Phase 2a Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 8/19/2015
Pacific Urological Research
mi
from
Victoria,
Click here to add this to my saved trials
Study of XL228 in Subjects With Chronic Myeloid Leukemia or Philadelphia-Chromosome-Positive Acute Lymphocytic Leukemia
A Phase 1 Dose-Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of XL228 Administered Intravenously to Subjects With Chronic Myeloid Leukemia (CML) or Philadelphia-Chromosome-Positive Acute Lymphocytic Leukemia (Ph+ ALL)
Status: Enrolling
Updated:  8/19/2015
UCLA School of Medicine
mi
from
Los Angeles, CA
Study of XL228 in Subjects With Chronic Myeloid Leukemia or Philadelphia-Chromosome-Positive Acute Lymphocytic Leukemia
A Phase 1 Dose-Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of XL228 Administered Intravenously to Subjects With Chronic Myeloid Leukemia (CML) or Philadelphia-Chromosome-Positive Acute Lymphocytic Leukemia (Ph+ ALL)
Status: Enrolling
Updated: 8/19/2015
UCLA School of Medicine
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study of XL228 in Subjects With Chronic Myeloid Leukemia or Philadelphia-Chromosome-Positive Acute Lymphocytic Leukemia
A Phase 1 Dose-Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of XL228 Administered Intravenously to Subjects With Chronic Myeloid Leukemia (CML) or Philadelphia-Chromosome-Positive Acute Lymphocytic Leukemia (Ph+ ALL)
Status: Enrolling
Updated:  8/19/2015
University of California at San Francisco
mi
from
San Francisco, CA
Study of XL228 in Subjects With Chronic Myeloid Leukemia or Philadelphia-Chromosome-Positive Acute Lymphocytic Leukemia
A Phase 1 Dose-Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of XL228 Administered Intravenously to Subjects With Chronic Myeloid Leukemia (CML) or Philadelphia-Chromosome-Positive Acute Lymphocytic Leukemia (Ph+ ALL)
Status: Enrolling
Updated: 8/19/2015
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Study of XL228 in Subjects With Chronic Myeloid Leukemia or Philadelphia-Chromosome-Positive Acute Lymphocytic Leukemia
A Phase 1 Dose-Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of XL228 Administered Intravenously to Subjects With Chronic Myeloid Leukemia (CML) or Philadelphia-Chromosome-Positive Acute Lymphocytic Leukemia (Ph+ ALL)
Status: Enrolling
Updated:  8/19/2015
Georgetown University Medical Center, Lombardi Comprehensive Cancer Center
mi
from
Washington,
Study of XL228 in Subjects With Chronic Myeloid Leukemia or Philadelphia-Chromosome-Positive Acute Lymphocytic Leukemia
A Phase 1 Dose-Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of XL228 Administered Intravenously to Subjects With Chronic Myeloid Leukemia (CML) or Philadelphia-Chromosome-Positive Acute Lymphocytic Leukemia (Ph+ ALL)
Status: Enrolling
Updated: 8/19/2015
Georgetown University Medical Center, Lombardi Comprehensive Cancer Center
mi
from
Washington,
Click here to add this to my saved trials
Study of XL228 in Subjects With Chronic Myeloid Leukemia or Philadelphia-Chromosome-Positive Acute Lymphocytic Leukemia
A Phase 1 Dose-Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of XL228 Administered Intravenously to Subjects With Chronic Myeloid Leukemia (CML) or Philadelphia-Chromosome-Positive Acute Lymphocytic Leukemia (Ph+ ALL)
Status: Enrolling
Updated:  8/19/2015
H. Lee Moffitt Cancer Center & Research Institute
mi
from
Tampa, FL
Study of XL228 in Subjects With Chronic Myeloid Leukemia or Philadelphia-Chromosome-Positive Acute Lymphocytic Leukemia
A Phase 1 Dose-Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of XL228 Administered Intravenously to Subjects With Chronic Myeloid Leukemia (CML) or Philadelphia-Chromosome-Positive Acute Lymphocytic Leukemia (Ph+ ALL)
Status: Enrolling
Updated: 8/19/2015
H. Lee Moffitt Cancer Center & Research Institute
mi
from
Tampa, FL
Click here to add this to my saved trials
Study of XL228 in Subjects With Chronic Myeloid Leukemia or Philadelphia-Chromosome-Positive Acute Lymphocytic Leukemia
A Phase 1 Dose-Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of XL228 Administered Intravenously to Subjects With Chronic Myeloid Leukemia (CML) or Philadelphia-Chromosome-Positive Acute Lymphocytic Leukemia (Ph+ ALL)
Status: Enrolling
Updated:  8/19/2015
University of Michigan Health System
mi
from
Ann Arbor, MI
Study of XL228 in Subjects With Chronic Myeloid Leukemia or Philadelphia-Chromosome-Positive Acute Lymphocytic Leukemia
A Phase 1 Dose-Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of XL228 Administered Intravenously to Subjects With Chronic Myeloid Leukemia (CML) or Philadelphia-Chromosome-Positive Acute Lymphocytic Leukemia (Ph+ ALL)
Status: Enrolling
Updated: 8/19/2015
University of Michigan Health System
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Study of XL228 in Subjects With Chronic Myeloid Leukemia or Philadelphia-Chromosome-Positive Acute Lymphocytic Leukemia
A Phase 1 Dose-Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of XL228 Administered Intravenously to Subjects With Chronic Myeloid Leukemia (CML) or Philadelphia-Chromosome-Positive Acute Lymphocytic Leukemia (Ph+ ALL)
Status: Enrolling
Updated:  8/19/2015
M.D. Anderson Cancer Center
mi
from
Houston, TX
Study of XL228 in Subjects With Chronic Myeloid Leukemia or Philadelphia-Chromosome-Positive Acute Lymphocytic Leukemia
A Phase 1 Dose-Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of XL228 Administered Intravenously to Subjects With Chronic Myeloid Leukemia (CML) or Philadelphia-Chromosome-Positive Acute Lymphocytic Leukemia (Ph+ ALL)
Status: Enrolling
Updated: 8/19/2015
M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Evaluation of Oral Hygiene Products in an In Situ Caries Model
Clinical Evaluation of Oral Hygiene Products in an In Situ Caries Model
Status: Enrolling
Updated:  8/24/2015
GSK Investigational Site
mi
from
Indianapolis, IN
Evaluation of Oral Hygiene Products in an In Situ Caries Model
Clinical Evaluation of Oral Hygiene Products in an In Situ Caries Model
Status: Enrolling
Updated: 8/24/2015
GSK Investigational Site
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Surgical Reduction of the Inferior Turbinates for Nasal Obstruction
Surgical Reduction of the Inferior Turbinate Using a Coblation® Device for Treatment of Nasal Obstruction: A Prospective, Multi-center Clinical Study
Status: Enrolling
Updated:  8/25/2015
Children's Hospital, San Diego
mi
from
San Diego, CA
Surgical Reduction of the Inferior Turbinates for Nasal Obstruction
Surgical Reduction of the Inferior Turbinate Using a Coblation® Device for Treatment of Nasal Obstruction: A Prospective, Multi-center Clinical Study
Status: Enrolling
Updated: 8/25/2015
Children's Hospital, San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
Surgical Reduction of the Inferior Turbinates for Nasal Obstruction
Surgical Reduction of the Inferior Turbinate Using a Coblation® Device for Treatment of Nasal Obstruction: A Prospective, Multi-center Clinical Study
Status: Enrolling
Updated:  8/25/2015
Center for Pediatric ENT
mi
from
Boynton Beach, FL
Surgical Reduction of the Inferior Turbinates for Nasal Obstruction
Surgical Reduction of the Inferior Turbinate Using a Coblation® Device for Treatment of Nasal Obstruction: A Prospective, Multi-center Clinical Study
Status: Enrolling
Updated: 8/25/2015
Center for Pediatric ENT
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
Surgical Reduction of the Inferior Turbinates for Nasal Obstruction
Surgical Reduction of the Inferior Turbinate Using a Coblation® Device for Treatment of Nasal Obstruction: A Prospective, Multi-center Clinical Study
Status: Enrolling
Updated:  8/25/2015
Advanced ENT & Allergy
mi
from
Louisville, KY
Surgical Reduction of the Inferior Turbinates for Nasal Obstruction
Surgical Reduction of the Inferior Turbinate Using a Coblation® Device for Treatment of Nasal Obstruction: A Prospective, Multi-center Clinical Study
Status: Enrolling
Updated: 8/25/2015
Advanced ENT & Allergy
mi
from
Louisville, KY
Click here to add this to my saved trials
Surgical Reduction of the Inferior Turbinates for Nasal Obstruction
Surgical Reduction of the Inferior Turbinate Using a Coblation® Device for Treatment of Nasal Obstruction: A Prospective, Multi-center Clinical Study
Status: Enrolling
Updated:  8/25/2015
Pediatric Otolaryngology Nationwide Children's Hospital
mi
from
Columbus, OH
Surgical Reduction of the Inferior Turbinates for Nasal Obstruction
Surgical Reduction of the Inferior Turbinate Using a Coblation® Device for Treatment of Nasal Obstruction: A Prospective, Multi-center Clinical Study
Status: Enrolling
Updated: 8/25/2015
Pediatric Otolaryngology Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Surgical Reduction of the Inferior Turbinates for Nasal Obstruction
Surgical Reduction of the Inferior Turbinate Using a Coblation® Device for Treatment of Nasal Obstruction: A Prospective, Multi-center Clinical Study
Status: Enrolling
Updated:  8/25/2015
Children'S Hospital
mi
from
Aurora, CO
Surgical Reduction of the Inferior Turbinates for Nasal Obstruction
Surgical Reduction of the Inferior Turbinate Using a Coblation® Device for Treatment of Nasal Obstruction: A Prospective, Multi-center Clinical Study
Status: Enrolling
Updated: 8/25/2015
Children'S Hospital
mi
from
Aurora, CO
Click here to add this to my saved trials
Combined Behavioral and Drug Treatment of Overactive Bladder in Men
Combined Behavioral and Drug Treatment of Overactive Bladder in Men
Status: Enrolling
Updated:  8/26/2015
University of Alabama at Birmingham
mi
from
Birmingham, AL
Combined Behavioral and Drug Treatment of Overactive Bladder in Men
Combined Behavioral and Drug Treatment of Overactive Bladder in Men
Status: Enrolling
Updated: 8/26/2015
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Combined Behavioral and Drug Treatment of Overactive Bladder in Men
Combined Behavioral and Drug Treatment of Overactive Bladder in Men
Status: Enrolling
Updated:  8/26/2015
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
Combined Behavioral and Drug Treatment of Overactive Bladder in Men
Combined Behavioral and Drug Treatment of Overactive Bladder in Men
Status: Enrolling
Updated: 8/26/2015
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
Combined Behavioral and Drug Treatment of Overactive Bladder in Men
Combined Behavioral and Drug Treatment of Overactive Bladder in Men
Status: Enrolling
Updated:  8/26/2015
Emory University
mi
from
Atlanta, GA
Combined Behavioral and Drug Treatment of Overactive Bladder in Men
Combined Behavioral and Drug Treatment of Overactive Bladder in Men
Status: Enrolling
Updated: 8/26/2015
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Workshops for Veterans With Vision and Hearing Loss
Pilot Study: Self Management Groups for Veterans With Dual Sensory Loss
Status: Enrolling
Updated:  8/28/2015
Atlanta VA Medical and Rehab Center, Decatur
mi
from
Decatur, GA
Workshops for Veterans With Vision and Hearing Loss
Pilot Study: Self Management Groups for Veterans With Dual Sensory Loss
Status: Enrolling
Updated: 8/28/2015
Atlanta VA Medical and Rehab Center, Decatur
mi
from
Decatur, GA
Click here to add this to my saved trials
Workshops for Veterans With Vision and Hearing Loss
Pilot Study: Self Management Groups for Veterans With Dual Sensory Loss
Status: Enrolling
Updated:  8/28/2015
VA Portland Health Care System, Portland, OR
mi
from
Portland, OR
Workshops for Veterans With Vision and Hearing Loss
Pilot Study: Self Management Groups for Veterans With Dual Sensory Loss
Status: Enrolling
Updated: 8/28/2015
VA Portland Health Care System, Portland, OR
mi
from
Portland, OR
Click here to add this to my saved trials
Pediatric Critical Illness Hyperglycemia and Glycemic Control Registry
Pediatric Critical Illness Hyperglycemia and Glycemic Control Registry: A Project to Assist in the Improved Understanding of Hyperglycemia and Glycemic Control in Pediatric Critical Illness.
Status: Enrolling
Updated:  8/28/2015
Children's Healthcare of Atlanta at Egleston - Pediatric Cardiac Intensive Care Unit
mi
from
Atlanta, GA
Pediatric Critical Illness Hyperglycemia and Glycemic Control Registry
Pediatric Critical Illness Hyperglycemia and Glycemic Control Registry: A Project to Assist in the Improved Understanding of Hyperglycemia and Glycemic Control in Pediatric Critical Illness.
Status: Enrolling
Updated: 8/28/2015
Children's Healthcare of Atlanta at Egleston - Pediatric Cardiac Intensive Care Unit
mi
from
Atlanta, GA
Click here to add this to my saved trials
Pediatric Critical Illness Hyperglycemia and Glycemic Control Registry
Pediatric Critical Illness Hyperglycemia and Glycemic Control Registry: A Project to Assist in the Improved Understanding of Hyperglycemia and Glycemic Control in Pediatric Critical Illness.
Status: Enrolling
Updated:  8/28/2015
Children's Healthcare of Atlanta at Egleston - Pediatric Intensive Care Unit
mi
from
Atlanta, GA
Pediatric Critical Illness Hyperglycemia and Glycemic Control Registry
Pediatric Critical Illness Hyperglycemia and Glycemic Control Registry: A Project to Assist in the Improved Understanding of Hyperglycemia and Glycemic Control in Pediatric Critical Illness.
Status: Enrolling
Updated: 8/28/2015
Children's Healthcare of Atlanta at Egleston - Pediatric Intensive Care Unit
mi
from
Atlanta, GA
Click here to add this to my saved trials
Pediatric Critical Illness Hyperglycemia and Glycemic Control Registry
Pediatric Critical Illness Hyperglycemia and Glycemic Control Registry: A Project to Assist in the Improved Understanding of Hyperglycemia and Glycemic Control in Pediatric Critical Illness.
Status: Enrolling
Updated:  8/28/2015
Medical Center of Central Georgia - Pediatric Intensive Care Unit
mi
from
Macon, GA
Pediatric Critical Illness Hyperglycemia and Glycemic Control Registry
Pediatric Critical Illness Hyperglycemia and Glycemic Control Registry: A Project to Assist in the Improved Understanding of Hyperglycemia and Glycemic Control in Pediatric Critical Illness.
Status: Enrolling
Updated: 8/28/2015
Medical Center of Central Georgia - Pediatric Intensive Care Unit
mi
from
Macon, GA
Click here to add this to my saved trials
Diagnostic Utility of Tetra-NIRS in Conjunction With Urodynamic Studies
The Purpose of This Experiment is to Validate the Previous Clinical Study Results Using the Tetra-NIRS (Near Infrared Spectroscopy) as Compared to the Conventional UDS in the Voiding Procedure. This Evaluation Will Use a Commercially Available Tetra-NIRS Device.
Status: Enrolling
Updated:  8/31/2015
Vanderbilt University
mi
from
Nashville, TN
Diagnostic Utility of Tetra-NIRS in Conjunction With Urodynamic Studies
The Purpose of This Experiment is to Validate the Previous Clinical Study Results Using the Tetra-NIRS (Near Infrared Spectroscopy) as Compared to the Conventional UDS in the Voiding Procedure. This Evaluation Will Use a Commercially Available Tetra-NIRS Device.
Status: Enrolling
Updated: 8/31/2015
Vanderbilt University
mi
from
Nashville, TN
Click here to add this to my saved trials
Diagnostic Utility of Tetra-NIRS in Conjunction With Urodynamic Studies
The Purpose of This Experiment is to Validate the Previous Clinical Study Results Using the Tetra-NIRS (Near Infrared Spectroscopy) as Compared to the Conventional UDS in the Voiding Procedure. This Evaluation Will Use a Commercially Available Tetra-NIRS Device.
Status: Enrolling
Updated:  8/31/2015
Sunnybrook Health Sciences Centre
mi
from
Toronto,
Diagnostic Utility of Tetra-NIRS in Conjunction With Urodynamic Studies
The Purpose of This Experiment is to Validate the Previous Clinical Study Results Using the Tetra-NIRS (Near Infrared Spectroscopy) as Compared to the Conventional UDS in the Voiding Procedure. This Evaluation Will Use a Commercially Available Tetra-NIRS Device.
Status: Enrolling
Updated: 8/31/2015
Sunnybrook Health Sciences Centre
mi
from
Toronto,
Click here to add this to my saved trials